SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
dongge
Lv1
38 积分
2023-06-08 加入
最近求助
最近应助
互助留言
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): a single-arm, phase II study
17天前
已完结
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
1个月前
已完结
m6A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression
1个月前
已完结
USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2
1个月前
已完结
Modern Innovations in Breast Surgery: Robotic Breast Surgery and Robotic Breast Reconstruction
2个月前
已完结
TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway
2个月前
已完结
Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer
2个月前
已完结
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2个月前
已完结
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity
2个月前
已完结
Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer
2个月前
已完结
没有进行任何应助
J Clin Oncol (IF: 32.956) . 2023 Sep 10;41(26):4192-4199. doi: 10.1200/JCO.22.02511.
2个月前
求助过了【积分已退回】
8个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论